Moreover, in bladder cancer, CAFs-derived miR-146a-5p was demonstrated to foster CSC niche formation and cancer stemness to drive chemoresistance via co-targeting ARID1A and PRKAA2 (also known as AMPKα2) [89]. This evidence concerns the gene PRKAA2 and urinary bladder cancer.